Among the deaths recorded for a given year, some could be avoided through prevention (public health and primary prevention interventions on risky behaviors: smoking, alcohol, risky behavior, vaccine-preventable diseases, etc.) or through treatment. (effective and timely health care).
Drees therefore estimated, for 2022, that 135.3 deaths per 100,000 inhabitants under 75 could have been avoided thanks to primary prevention. Treatment-avoidable mortality was 60.8/100,000 inhabitants. Thus, as in all European Union countries, mortality linked to primary prevention in France is higher than that linked to treatment.
Finally, the avoidable mortality rate is much higher in men than in women (263.5 versus 128.8 deaths/100,000 inhabitants). It is in particular the component linked to primary prevention which is in question: 197.5 deaths for men compared to 73.2 deaths for women, while that linked to treatments is similar (66.0 and 56.6 deaths respectively ).
To conclude, these two studies confirm a break in the downward trend in mortality observed between 2015 and 2019, for all-cause mortality and for the majority of major causes taken in isolation – except cancers. Thus, the increase in mortality will continue in 2022, particularly for endocrine and digestive system diseases. In previous articles, we have already mentioned and analyzed the abnormal trajectory of life expectancy in France in recent years.
